We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put NantKwest, Inc.'s financial performance into perspective.
Aug 03, 2020 | Press Releases
Preclinical results show this next generation Adeno (hAd5) vaccine, which targets both
Jul 07, 2020 | Press Releases
Jun 29, 2020 | Press Releases
EL SEGUNDO, Calif. --(BUSINESS WIRE)--Jun. 29, 2020-- NantKwest, Inc. (Nasdaq: NK), a